These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22795635)

  • 21. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
    Wiener J; Quinn JP; Bradford PA; Goering RV; Nathan C; Bush K; Weinstein RA
    JAMA; 1999 Feb; 281(6):517-23. PubMed ID: 10022107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic resistance patterns of more than 120 000 clinical Escherichia coli isolates in Southeast Austria, 1998-2013.
    Badura A; Feierl G; Pregartner G; Krause R; Grisold AJ
    Clin Microbiol Infect; 2015 Jun; 21(6):569.e1-7. PubMed ID: 25704445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn R; McDermott TE; Murphy P; Grainger R; Fennell JP; Thornhill JA
    Ir J Med Sci; 2013 Mar; 182(1):81-9. PubMed ID: 22669684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.
    Lepeule R; Leflon-Guibout V; Vanjak D; Zahar JR; Lafaurie M; Besson C; Lefort A;
    Med Mal Infect; 2014 Dec; 44(11-12):530-4. PubMed ID: 25311839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Widespread Presence of a Multidrug-Resistant Escherichia coli ST131 Clade among Community-Associated and Hospitalized Patients.
    den Reijer PM; van Burgh S; Burggraaf A; Ossewaarde JM; van der Zee A
    PLoS One; 2016; 11(3):e0150420. PubMed ID: 26930662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
    Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
    Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
    Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
    Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends of fluoroquinolone-resistant Escherichia coli amongst urinary isolates in children: a 10 year surveillance study.
    Rosé L; Coulter MM; Chan S; Hossain J; Di Pentima MC
    J Med Microbiol; 2015 Jul; 64(7):778-781. PubMed ID: 26231748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary tract infection. Diabetics and non-diabetic patients.
    Akbar DH
    Saudi Med J; 2001 Apr; 22(4):326-9. PubMed ID: 11331489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.
    Hoshide RR; Chung H; Tokeshi J
    Hawaii Med J; 2011 Sep; 70(9):193-5. PubMed ID: 22162614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.
    Thaden JT; Fowler VG; Sexton DJ; Anderson DJ
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):49-54. PubMed ID: 26458226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli.
    Wu HH; Liu HY; Lin YC; Hsueh PR; Lee YJ
    J Microbiol Immunol Infect; 2016 Jun; 49(3):424-9. PubMed ID: 22560475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
    Horie A; Nariai A; Katou F; Abe Y; Saito Y; Koike D; Hirade T; Ito T; Wakuri M; Fukuma A
    Clin Exp Nephrol; 2019 Nov; 23(11):1306-1314. PubMed ID: 31428892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G; Poulsen HO
    Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differences between species involved and fluoroquinolone resistance patterns of strains isolated from bacteriuria according to nosocomial, health-related or community-acquired onset].
    Tassain J; N'Guyen Y; Batalla AS; Duval V; Guillard T; De Champs C; Strady C
    Presse Med; 2012 Dec; 41(12 Pt 1):e586-93. PubMed ID: 22727916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.
    Meng X; Liu S; Duan J; Huang X; Zhou P; Xiong X; Gong R; Zhang Y; Liu Y; Fu C; Li C; Wu A
    BMC Infect Dis; 2017 Jan; 17(1):82. PubMed ID: 28095785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.